APA

Pinzone M. R., Zanghì A. M., Rapisarda L., D'Agata V., Benanti F., Spartà D., Nunnari G. & Cacopardo B. (20150501). Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. : European review for medical and pharmacological sciences.

Chicago

Pinzone M R, Zanghì A M, Rapisarda L, D'Agata V, Benanti F, Spartà D, Nunnari G and Cacopardo B. 20150501. Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. : European review for medical and pharmacological sciences.

Harvard

Pinzone M. R., Zanghì A. M., Rapisarda L., D'Agata V., Benanti F., Spartà D., Nunnari G. and Cacopardo B. (20150501). Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. : European review for medical and pharmacological sciences.

MLA

Pinzone M R, Zanghì A M, Rapisarda L, D'Agata V, Benanti F, Spartà D, Nunnari G and Cacopardo B. Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. : European review for medical and pharmacological sciences. 20150501.